Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Taro Pharm Inds (NY: TARO ) 42.97 UNCHANGED Last Price Updated: 7:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 42.97 Bid (Size) 41.50 (1) Ask (Size) 43.97 (50) Prev. Close 42.97 Today's Range 42.97 - 42.97 52wk Range 32.67 - 45.76 Shares Outstanding 37,584,631 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News TARO Stock Earnings: Taro Pharmaceutical Indus Reported Results for Q4 2024 May 20, 2024 Taro Pharmaceutical Indus just reported results for the fourth quarter of 2024. Via InvestorPlace Taro Provides Results for Year Ended March 31, 2024 May 20, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire Performance YTD +2.90% +2.90% 1 Month +0.68% +0.68% 3 Month +1.75% +1.75% 6 Month +2.90% +2.90% 1 Year +13.29% +13.29% More News Read More Taro to Release Full Year Results on May 20, 2024 May 15, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger May 08, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO April 22, 2024 From Kahn Swick & Foti, LLC Via Business Wire Earnings Preview For Taro Pharmaceutical Indus January 24, 2024 Via Benzinga Taro Pharmaceutical Indus Earnings Preview October 25, 2023 Via Benzinga Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd. April 15, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO February 06, 2024 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI) January 26, 2024 From Brodsky & Smith LLC Via GlobeNewswire Why Shares of Taro Pharmaceutical Are Rising Tuesday May 30, 2023 Via The Motley Fool Taro Provides Results for December 31, 2023 January 25, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI) January 22, 2024 From Brodsky & Smith LLC Via GlobeNewswire Taro to Release Third Quarter Results on January 25, 2024 January 19, 2024 From Taro Pharmaceutical Industries Ltd. Via Business Wire Earnings Scheduled For January 25, 2024 January 25, 2024 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: M.D.C. Holdings, Inc. (NYSE - MDC), Cornerstone Financial Corporation (OTC - CFIC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - January 18, 2024 From Brodsky & Smith LLC Via GlobeNewswire TARO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Taro Pharmaceutical Industries Ltd. Is Fair to Shareholders January 17, 2024 From Halper Sadeh LLC Via Business Wire Taro Provides Results for September 30, 2023 October 26, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Earnings Scheduled For October 26, 2023 October 26, 2023 Via Benzinga Taro to Release Second Quarter Results on October 26, 2023 October 19, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Provides Results for the Quarter Ended June 30, 2023 July 26, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro to Release First Quarter Results on July 26, 2023 July 19, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023 June 30, 2023 From Taro Pharmaceutical Industries Ltd. Via Business Wire Taro Pharmaceutical Industries Ltd. (NYSE: TARO) Near the Top of Equities by Percentage Gain on 5/30 May 30, 2023 Via Investor Brand Network Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 30, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
